Literature DB >> 9044532

Evaluating treatments when a gender by treatment interaction may exist.

E Russek-Cohen1, R M Simon.   

Abstract

We propose a two-stage procedure for investigating whether males and females respond differently to treatment. The size of the first stage is based on the assumption of homogeneity of treatment effects across genders. Using stage I, we test for a gender by treatment interaction. If non-significant, we compute an overall average treatment effect and terminate the study. If we find an apparent interaction at the end of the first stage, we consider each gender separately. Because we now need to estimate treatment effects separately for each gender, we may have a need to collect additional information in a second stage. We consider the performance of our procedure for a normally distributed endpoint as well as for a survival model.

Mesh:

Year:  1997        PMID: 9044532     DOI: 10.1002/(sici)1097-0258(19970228)16:4<455::aid-sim382>3.0.co;2-y

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment.

Authors:  M Rosenblum; M J Van der Laan
Journal:  Biometrika       Date:  2011-12       Impact factor: 2.445

2.  Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.

Authors:  P A Rochon; J P Clark; M A Binns; V Patel; J H Gurwitz
Journal:  CMAJ       Date:  1998-08-25       Impact factor: 8.262

3.  Assessing the heterogeneity of treatment effects via potential outcomes of individual patients.

Authors:  Zhiwei Zhang; Chenguang Wang; Lei Nie; Guoxing Soon
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2013-11       Impact factor: 1.864

4.  Testing for efficacy in adaptive clinical trials with enrichment.

Authors:  Samuel S Wu; Yi-Hsuan Tu; Ying He
Journal:  Stat Med       Date:  2014-02-27       Impact factor: 2.373

5.  The Use of Covariates and Random Effects in Evaluating Predictive Biomarkers Under a Potential Outcome Framework.

Authors:  Zhiwei Zhang; Lei Nie; Guoxing Soon; Aiyi Liu
Journal:  Ann Appl Stat       Date:  2014-12-19       Impact factor: 2.083

6.  Confidence intervals for the selected population in randomized trials that adapt the population enrolled.

Authors:  Michael Rosenblum
Journal:  Biom J       Date:  2013-04-03       Impact factor: 2.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.